ARG1 and Hepatic fibrosis: Although, Arg-1 is typically considered a pro-fibrotic marker (78), expression of Arg-1 specifically by MΦ has been shown to limit excessive ECM deposition in models of liver fibrosis (79) and animals lacking Arg-1 expression specifically in myeloid cells fail to resolve atherosclerotic inflammation and disease progression (80).